Related by context. All words. (Click for frequent words.) 74 oncolytic virus therapies 73 Initiates Phase II 72 SECTA therapy 72 Initiates Enrollment 72 Completes Patient Enrollment 72 kidney urologic 72 HuMax TAC 72 Phase #b/#a clinical 72 product platforms AZX# 72 GVAX ® 71 delivery polymer matrix 71 SCIB1 71 Initiates Clinical Trial 71 proprietary capillary aerosolization 71 LymphoStat B TM 71 Provectus Pharmaceuticals specializes 71 P#X# antagonist 71 novel therapeutic antibodies 71 molecular chaperone regulation 71 CYT# potent vascular disrupting 71 acetonide FA 71 Generx ® 71 rxRNA 70 personalized cellular immunotherapy 70 platinum chemotherapeutic 70 proprietary PEGylation 70 visit www.genenews.com 70 candidate CRLX# 70 SinuNase ™ 70 Locked Nucleic Acid 70 Reports Preclinical Data 70 TRANSDUR ™ 70 vaccines oncolytic virus 70 ThermoDox ® clinical 70 Kosan dependence 70 novel VDA molecule 70 Immunotherapeutic 70 ALN PCS 70 visit http:/www.mannkindcorp.com 70 purinergic receptors P#X# 69 Levulan ® PDT 69 Initiates Phase III 69 candidates Azedra TM 69 NurOwn 69 XL# anticancer compounds 69 coronary stent merged 69 telomerase inhibitor drug 69 initiated Phase 1b 69 introduced NEUGENE 69 hypoxia activated prodrug 69 acyclovir Lauriad R 69 FOLOTYN ® 69 ELADUR ™ 69 Modrenal R 69 Begins Dosing 69 including eniluracil ADH 69 ATRA IV 69 NovaDel oral spray 69 Curaxin CBLC# 69 platform HDL Mimetic 69 please visit www.advaxis.com 69 novel peptides 69 sodium thiosulfate STS 69 Initiates Clinical 69 proprietary transdermal 69 subsidiaries visit http:/www.apricusbio.com 69 therapeutic monoclonal antibody 69 telomerase therapeutic 69 developing TB4 69 anti infective treatments 69 apricitabine ATC 69 recurrent metastatic ovarian cancer 69 Inc. AMEX YMI 69 novel emulsion formulation 69 PI3K/Akt pathway inhibitor 69 Combivir Kivexa 69 PORxin TM 69 Chimigen TM 69 Hsp# Inhibitor 69 PNP inhibitor 69 ImmunoGen TAP technology 69 TRIOLEX HE# APOPTONE HE# 68 Presents Preclinical Data 68 Adnectin 68 oral ghrelin agonist 68 enhanced skin permeation 68 pralatrexate injection folate analogue 68 AAG geldanamycin analog 68 deCODE AF TM 68 Panzem ® 68 Exelixis compounds 68 Announces Poster Presentations 68 HDL Selective Delipidation 68 skeletal sarcomere activators 68 evaluating satraplatin 68 romazarit 68 MedPulser 68 Oracea TM 68 Exherin 68 ThermoDox R 68 mertansine 68 agonistic human 68 Veronate R 68 MKC# MKC# PP 68 synthetic retinoid 68 Fludara ® 68 R Saizen R 68 CORTOSS R 68 regenerative stem cell 68 NTDDS 68 Therapeutic Competitors companiesandmarkets.com adEgemonye 68 orally inhaled migraine 68 oral salmon calcitonin 68 Locked Nucleic Acid LNA 68 Nasdaq MNKD focused 68 Empatic ™ 68 HDL Mimetic Peptide 68 tiapamil 68 mda 7 68 sapacitabine CYC# 68 Protexia ® 68 targeted radiotherapeutic 68 recombinant biopharmaceutical 68 Myocet 68 Resurgex Plus R 68 Nasdaq OMER biopharmaceutical 68 TRANSDUR ® 68 Myolimus 68 THR beta agonist 68 intravesical infusion therapy 68 PHX# 68 MSCRAMM ® 68 Zalypsis 68 4SC AG ISIN DE# 68 Allovectin 7 68 Panzem R 68 Prodarsan R 68 Therapeutic Competitors Companies 68 Presents Preclinical 68 R MSCRAMM 68 ZFP Therapeutics 68 Luveris R Ovidrel R 68 patented Bioral 68 NuMimetic TM 68 ARRY # 68 accumulate preferentially 68 Fibrin MB 68 successfully commercialize Iluvien 68 Personalized Immunotherapy 68 investigational immunotherapy 68 R sorafenib tablets 68 dermatology therapies 68 PORxin TM platforms 68 pipeline ImmunoGen collaborators 67 antibody MAb 67 Cardium Therapeutics TM 67 CCR9 antagonist 67 novel RNAi therapeutics 67 delivers fluocinolone acetonide FA 67 antiangiogenesis therapies 67 Initiate Clinical Trial 67 candidate deforolimus 67 Pharma Merck Serono 67 Receives Milestone Payment 67 trastuzumab DM1 T DM1 67 HuMax 67 Crofelemer budesonide foam 67 Files IND 67 hyaluronidase enzyme 67 International LAB Pharma 67 MAGE A3 ASCI 67 Nanobody R 67 SIX RO ROG 67 intranasal vaccines derived 67 Liprotamase 67 ddRNAi 67 Solazed TM 67 RECOTHROM ® 67 HGS ETR1 mapatumumab 67 Valortim TM 67 mocetinostat MGCD# 67 gastro intestinal inflammation 67 Homspera TM 67 Xcytrin R 67 Maxy G# 67 DOS# 67 include ColorectAlert TM 67 lintuzumab SGN 67 pharmacogenomic translational research 67 Dyax phage display 67 LungAlert TM 67 provides RevColor RevDisplay 67 About Positron Positron 67 Nasdaq HALO biopharmaceutical 67 PDE4 inhibitor 67 Avian Transgenic Technology 67 LymphoStat B belimumab 67 GeneICE 67 HuCNS SC ® 67 humanised monoclonal antibody 67 PGL# 67 TELINTRA R 67 orally administered inhibitor 67 PSMA ADC 67 TRACON Pharmaceuticals 67 please visit http:/www.vandapharma.com 67 candidate XP# 67 evaluating tivozanib 67 Aradigm Logo 67 developing Bicifadine serotonin 67 TÎ ² 4 67 proprietary MSCRAMM ® 67 BHT DNA 67 Receives CE Marking 67 IMiDs ® 67 Gastrointestinal Liner 67 MEK Inhibitor 67 Transdel TM 67 Initiates Dosing 67 OTCBB HNAB 67 INS# [001] 67 vaccine GRNVAC1 67 JAK2 Inhibitor 67 human IgG1 monoclonal 67 immunotherapeutics 67 Potelligent Technology 67 patented NanoStat ™ 67 2 methoxyestradiol 67 Awarded Qualifying Therapeutic 67 hormone LHRH antagonist 67 immunotherapeutic approaches 67 immunotherapeutic vaccine 67 cosmetic cosmeceutical products 67 VBLOC vagal blocking 67 PEGylated interferon 67 RNA antagonists 67 StromaCel Inc. 67 POTELLIGENT ® 67 EnteroMedics proprietary neuroblocking technology 67 HyACT 67 rusalatide acetate 67 orally bioavailable mimics 67 Nasdaq LXRX biopharmaceutical 67 Abstract Accepted 67 Completes Enrollment 67 Vitamin D analogue 67 Gentamicin Surgical Implant 67 Nasdaq XTLB 67 markets HP Acthar 67 Receives Orphan Drug Designation 67 Nektar proprietary 67 DP VPA 67 Novolimus 67 Intravenous Human 67 RhuDex R 67 FOLFOX6 chemotherapy regimen 67 BXT # 67 selective androgen receptor modulators 67 external counterpulsation systems 67 Submits Response 67 ArQule Kinase Inhibitor Platform 66 proprietary intranasal insulin 66 OMNARIS HFA 66 GVAX R 66 rALLy clinical trial 66 Alfacell proprietary ribonuclease 66 Initiates Clinical Trials 66 POTELLIGENT R 66 methylnaltrexone bromide 66 immunotherapies 2A/Furin 66 DEEP AF 66 targeted anticancer therapies 66 Homspera ® 66 TM Aganocide 66 PDE4 modulators 66 cytoskeletal pharmacology 66 SinuNase TM 66 induced macular edema 66 DiLA2 66 Elagolix 66 non personalized allogeneic 66 Aganocide 66 HepDirect prodrug 66 Nektar pulmonary 66 Vascular Wrap TM 66 Ceragenin ™ 66 Zorbtive TM 66 Nasdaq MITI biopharmaceutical 66 AcryMed Incorporated 66 OTCBB NPHC 66 Cx# [002] 66 Fleximer R 66 Ostabolin C TM 66 Submits Biologics License Application 66 catalytic antioxidant compounds 66 personalized dendritic 66 Survivin antagonist 66 vapreotide acetate 66 R lenalidomide 66 microsurgical disciplines 66 FUSILEV ® 66 Captisol ® 66 SEQureDx ™ 66 Tesmilifene 66 AQUA ® 66 candidate AQ4N 66 RONDEL ™ 66 tumor angiogenesis inhibitors 66 commercialize deforolimus 66 diagnostic molecular imaging 66 novel peptide 66 plasmid DNA pDNA 66 Nasdaq IMGN 66 Epigenomics proprietary 66 Targeted Chemotherapy 66 Nanobody ® 66 interferon alpha IFN 66 Pyridorin 66 Frankfurt XMP 66 GTC recombinant human 66 investigational monoclonal antibody 66 angiotensin analog 66 urethral bulking agent 66 selective androgen receptor modulator 66 JAK inhibitors 66 refractory chronic lymphocytic 66 LEVADEX ™ 66 Evoltra ® 66 Symphony tCGM 66 KL4 Surfactant 66 lexidronam injection 66 Chrysalin 66 fatty acid amide hydrolase 66 Nasdaq CYTR biopharmaceutical 66 InterfeRx TM 66 molecular imaging radiopharmaceutical 66 Pentad TM 66 INxin 66 syndrome overactive bladder 66 Sangamo ZFP TF 66 NYSE Amex YMI 66 NASDAQ ABII 66 forodesine 66 AcryMed technologies 66 IMiDs R 66 Ketotransdel 66 OncoVex 66 2 inhibitor CYT# 66 inflammatory autoimmune diseases 66 oral prodrug 66 Prestara TM 66 Submits NDA 66 EHT AGN 66 RECOTHROM R 66 Staccato nicotine technology 66 Bioral 66 MKC# MT 66 OTCBB NRGX 66 NYSE Amex PBTH 66 Aganocide ® 66 Albugon 66 Cleviprex TM clevidipine 66 BioSante Pharmaceuticals Announces 66 novel proprietary KL4 66 demonstrated antitumor activity 66 Adenosine Therapeutics 66 candidate TNFerade biologic 66 TransVax ™ 66 commercializing anti infective 66 Revimmune TM 66 Prednisporin 66 TRAIL receptor antibodies 66 Enhanze 66 HPV cervical dysplasia 66 Resten NG 66 please visit www.medicinova.com 66 autologous cellular therapy 66 cMET 66 Hedgehog Pathway Inhibitor 66 please visit http:/www.sunesis.com 66 nasal calcitonin product 66 BioFocus DPI Galapagos 66 CVac 66 BCR ABL inhibitors 66 progressive metastatic prostate 66 ENMD # 66 http:/www.unigene.com 66 AVEO Pharmaceuticals NASDAQ 66 MP4 molecule 66 Tovaxin ® 65 aerosolized AAT 65 XL# XL# XL# XL# 65 MCSP respectively 65 manufactures minimally invasive 65 anti botulism antibody 65 peptidic compound 65 vivo fluorescence imaging 65 attach auristatin 65 Inc. OTCBB ALRX 65 fusion enhancers 65 CD# CEA 65 Cethrin R 65 LentiVector technology 65 trial evaluating PRX# 65 Telik logo TELINTRA 65 OTCBB PYTO 65 HuCAL PLATINUM ® CysDisplay 65 Fc fusion protein 65 humanized monoclonal 65 Successfully Completes Phase 65 NovaBay Aganocide compounds 65 lead molecular radiotherapeutic 65 cellular immunotherapy 65 R#/MEM 65 Paris IPN Euronext 65 Combination REOLYSIN R 65 corticotropin injection 65 5 lipoxygenase activating 65 Vitrasert R 65 FDA APPROVES 65 initiated Phase Ib 65 PMX # heptagonist 65 Nasdaq RXII 65 vinorelbine tartrate 65 selective immunoproteasome inhibitor 65 targeted anticancer biopharmaceuticals 65 Nanobody 65 MOVIPREP R 65 midstage clinical 65 TSX CTI 65 derivatives Radilex TM 65 Mesoblast Limited ASX MSB 65 Vacuum Assisted Closure 65 Inc Therapeutic Competitors 65 aurora kinase 65 HepDirect R 65 OTCBB HXBM developer 65 Hedgehog agonist 65 mitiglinide 65 HGS# 65 OTCBB CHKT 65 HepDirect 65 antisense inhibitors 65 RELOVAIR ™ 65 HIV maturation inhibition 65 AERx ® 65 Monoclonal antibody 65 OTCQX QRXPY 65 visit www.genmab.com 65 SPRIX ® 65 SPL# Gel vaginal microbicide 65 XP# XP# 65 Inc. www.micromet inc.com 65 UltiMAb 65 ChronVac C R 65 EndoTAG TM 65 targeted antifolate 65 Cotavance 65 catheter occlusion 65 LHRH receptor positive 65 Cyclosert TM 65 Predictive medicine 65 Receives Orphan Drug 65 ospemifene 65 sodium Injection 65 programs visit http:/www.bionovo.com 65 eTag assays 65 markets Testim ® 65 Systemic Delivery 65 novel immunotherapies 65 Intarcia 65 Xeloda ® 65 Ad5FGF 4 65 BCLI 65 Brussels THR 65 Inotek Pharmaceuticals Corporation 65 DXL TM 65 MassARRAY ® 65 IL# PE#QQR 65 Neulasta R 65 small molecule thrombopoietin 65 CORT # 65 Achieves Primary Endpoint 65 PrevOnco ™ 65 proprietary Customized Linker 65 telomerase inhibitor 65 developing ACAPODENE 65 Fortical ® 65 IV Busulfex 65 theranostic 65 Licenses Novel 65 polyneuropathy HIV DSP 65 Surfaxin LS 65 leading lipid nanoparticle 65 Factor Receptor 65 Bucindolol 65 Medisorb R 65 evaluating bafetinib 65 volociximab 65 eligen 65 individualized cellular immunotherapy 65 Inc. NASDAQ IDMI 65 Zemiva TM 65 ABL inhibitor 65 Inc. OTCBB SPRX 65 Prochymal TM 65 Marqibo TM 65 sarcoma melanoma 65 optical biosensors 65 ZFN TM 65 molecular therapeutics immunotherapies 65 AEG# 65 thetreatment 65 IG HCR ;) CO 65 regarding Aethlon Medical 65 Vaccine Adjuvant 65 Announce Collaboration Agreement 65 Insegia 65 metaglidasen 65 Allovectin 7 R 65 M# rationally 65 SMaRT ™ 65 deforolimus 65 proprietary BiTE ® 65 liposomal delivery 65 vivo validation 65 PEGylated anti 65 GERD migraine headaches 65 NeuroSTAT ® 65 Genasense ® oblimersen 65 rhIGF-I/rhIGFBP-3 65 vitreoretinal disorders 65 DG# compounds targeting 65 HuCAL GOLD ® 65 investigational pharmacologically unique 65 Genasense evaluating 65 EECP R 65 Novel Antibody 65 Virium 65 liposomal formulation 65 TKB# 65 proprietary bioresorbable polymer 65 Phase IIb clinical trials 65 TLR9 agonist 65 cisplatin gemcitabine 65 Iluvien ® 65 therapy Tovaxin 65 orthobiologic 65 Colaris Colaris AP 65 Squalamine 65 Enrolls First 65 commercialize becocalcidiol patented 65 Endologix Powerlink System 65 Optical Biopsy System 65 Generx TM 65 peptide conjugated 65 visit biotech.com 65 TIMERx 65 Urocortin 2 65 ALN HPN 65 Present Preclinical Data 65 immune modulating drug 65 Novel Oral 65 highly selective inhibitor 65 Ceflatonin R 65 therapeutic monoclonal antibodies 65 CTAP# Capsules 65 brand ciclesonide HFA 65 novel antibody therapeutics 65 Receives Approvable Letter 65 Endotis 65 ArQule Kinase Inhibitor 65 PF # [002] 65 novel oral anticoagulant 65 Cobalamin TM mediated 65 developing chemokine 65 Uvidem 65 proprietary radiolabeled monoclonal 65 MEK inhibitors 65 MSCRAMM R 65 Panzem R NCD 65 Myriad logo BRACAnalysis 65 VitiGam 65 PEGylation technology 65 glucokinase activator 65 LNP formulations 65 product candidate Lpathomab 65 Genentech sanofi aventis 65 small molecule chemopotentiator 65 proprietary BiTE R 65 DNA RNA Medicines 65 HepeX B 65 TNF Tumor Necrosis Factor 65 Tibotec BVBA 65 5 HT3 antagonist 65 Angiocept 65 Chipscreen 65 Syndax Pharmaceuticals Inc. 65 ALVESCO ® 65 YONDELIS 65 CysDisplay R 65 Phase IIb III 65 DermaPrep 65 Tovaxin TM 65 Enzyme Replacement Therapy 65 treat refractory angina 65 pharmacological chaperone 65 Completes Dosing 65 metastatic colorectal 65 investigational humanized monoclonal antibody 65 Testim R 65 IMPACS R 65 Cobalamin TM 65 SuperAntibody 65 technology visit http:/www.genmab.com 65 tests miRview TM 65 Vidaza ® 65 By JENNIFER LEARN 65 Synavive ™ 65 Phusion Laboratories 65 Pruvel TM 65 IRX 2 65 Granted Orphan Drug 65 Oncobionic 65 RNAi Therapeutic 65 IAP inhibitors 65 BCG refractory carcinoma 65 Zolpimist ™ 65 oral transdermal 65 website http:/www.celsion.com 65 Tumour Vascular Disrupting Agent 65 AMEX REX 65 Therapeutic Vaccine 65 Quark Biotech 65 ONCONASE R 65 transfection reagents 64 ImmunoBody ® 64 Peyronie disease Frozen Shoulder 64 Vaxfectin TM 64 AVEO integrates proprietary 64 non porcine pancreatic 64 BrachySil ™ 64 OncoVEX 64 ONCASPAR 64 Announce License Agreement 64 FORMA Therapeutics 64 NRGN 64 Sudhir Agrawal D.Phil 64 Omacetaxine 64 prokinetic agent 64 Gonal f R 64 Genentech Wyeth Pharmaceuticals 64 candidate epratuzumab 64 novel anti infective 64 generation radiolabeled antibody 64 acadesine 64 HuCAL antibodies 64 GIPET 64 Taiho Pharmaceutical 64 HuLuc# 64 stable nucleic acid 64 protein tyrosine phosphatase 1B 64 homocysteine assay 64 HuCAL PLATINUM R 64 QuadraSphere 64 doxorubicin Transdrug R 64 SPRYCEL ® 64 Biomerix Corporation 64 Genotyping Test 64 sirtuin inhibitor program 64 LEAPS TM 64 Inc. Nasdaq LXRX 64 interferon gamma 1b 64 NeutroPhase TM 64 Commences Phase 64 ARIKACE ™ 64 monoclonal antibody MAb 64 GVAX cancer 64 Archexin 64 please visit www.dyax.com 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 Agonist MABA program 64 HSP# inhibitor 64 developing ostarine selective 64 INxin TM 64 COPEGUS therapy 64 DermTech International 64 Phase 1b clinical trials 64 Inc. NASDAQ ZLCS 64 website www.celsion.com 64 Deforolimus 64 rheumatoid arthritis thrombocytopenia 64 Retains CCG Investor Relations 64 human antibody therapeutics 64 GEM OS2 64 proprietary polysaccharide 64 Submits IND 64 OTCBB IMNR 64 dihydrochloride Tablets 64 ALTROPANE R 64 Meets Primary Endpoint 64 proprietary albumin fusion 64 IMiDs ® compound 64 commercializing therapeutic 64 oral nucleoside analogue 64 drug ISA# 64 Thrombin topical Recombinant 64 thalidomide Thalomid 64 peptibody 64 product platforms GVAX 64 AFREZZA TM 64 Ridaforolimus 64 www.pranabio.com 64 SomatoKine 64 vaginally administered lidocaine 64 Synvisc ONE 64 proprietary buccal 64 ALN TTR 64 intranasal insulin product 64 TELINTRA 64 label Lipofen R 64 anticancer therapeutics 64 NexVas TM 64 biochemical profiling 64 Elan NanoCrystal 64 HCV RNA polymerase 64 generation URAT1 inhibitor 64 UltiMAb ® 64 Inc. OTCBB CYKN 64 includes Dideco CarboMedics 64 OvaRex ® MAb 64 memantine HCl 64 Phase Ib IIa 64 EOS NASDAQ MELA 64 Onalta TM 64 Excellarate TM 64 Mg Usa 64 immunotherapeutic agent 64 SUPPRELIN R LA 64 DUROS 64 IgG1 monoclonal antibody 64 Inc. Nasdaq MITI 64 proprietary biomaterials 64 Inc. Nasdaq VIAP 64 vaccine GMK 64 SEQureDx TM 64 TransVax tm 64 tramiprosate Alzhemed TM 64 incyclinide 64 generation purine nucleoside 64 EVIZON TM 64 Etubics 64 Oral Calcitonin 64 ZFNs clinical trials 64 RapidMist 64 delta opioid receptor 64 OTCBB QTXB 64 TRIOLEX HE# 64 BiTE R 64 topically delivered 64 bevacizumab Avastin ® 64 DARA logo 64 GRNOPC1 contains 64 neuropathic pain metabolic diseases 64 MAXY G# 64 drug conjugate 64 non nucleoside HCV 64 HCV polymerase inhibitors 64 GATTEX ® 64 Inc. NASDAQ AEZS 64 Tarmogen 64 MEK inhibitor 64 Xcellerex FlexFactory 64 Friedreich Ataxia FRDA 64 Visit www.BASInc.com 64 Nereus Pharmaceuticals 64 EDEMA3 trial 64 JAK2 inhibitor 64 lenalidomide Revlimid R 64 ASX PGL 64 evaluating picoplatin 64 XmAb ® 64 Expression PACE 64 overactive bladder VANTAS R 64 fluorinated carbohydrate mimics 64 Nasdaq ENZN 64 NV1FGF 64 AERx R 64 MVA BN R 64 MGd 64 highly selective endothelin 64 signal averaging electrocardiography 64 vivo electroporation 64 Receive Milestone Payment 64 Tectin TM 64 PER.C6 ® production 64 Cellgate Inc. 64 Glufosfamide 64 Maribavir 64 Phase 2b Clinical Trial 64 isoform selective 64 INSPIRE Trial Phase III 64 OTC BB PVCT 64 IMiDs 64 LEVADEX TM 64 non nucleoside inhibitor 64 Restoraderm 64 novel histone deacetylase 64 HuCAL GOLD R 64 Nventa proprietary CoVal 64 PANVAC VF 64 Nasulin ™ 64 Includes KCI proprietary 64 endometriosis ovarian cysts 64 ERYtech 64 Oasmia 64 ADP receptor antagonist 64 Dicer Substrate Technology 64 alpha interferons 64 psoriasis rheumatoid arthritis 64 Proquin XR 64 Pimavanserin 64 Antibody Drug Conjugate 64 vinca alkaloid 64 inhibit oxidative stress 64 pediatric malignancies 64 Albuferon TM 64 Ovitrelle R Serostim 64 Vicinium TM 64 Immunomedics Announces 64 OMP #R# 64 ALN HTT 64 OMAPRO ™ 64 patented bacterial oxidation 64 taxane derivative 64 Cetrorelix 64 Canvaxin TM 64 NPC 1C 64 TKM PLK1 64 Presents Positive 64 generation NEUGENE antisense 64 oral proteasome inhibitor 64 products MKC# PP 64 Potelligent 64 chemosaturation 64 expanded autologous cellular 64 chimeric monoclonal antibody 64 Alnylam Pharmaceuticals Nasdaq ALNY 64 toenail onychomycosis 64 Crucell PER.C6 ® 64 APC Targeting Technology 64 novel orally inhaled 64 hereditary emphysema 64 anti aging glycopeptides 64 docetaxel Taxotere ® 64 DGAT1 inhibitors 64 Demonstrates Significant 64 Prolongs Survival 64 MyoCell TM 64 pentadentate logo R 64 commercialize CorMedix drug 64 HCD# [002] 64 Inc. www.chemaphor.com uses 64 EP #R 64 AMEX RGN 64 anti CD3 monoclonal 64 Skin Cholesterol Test 64 Factor VIIa 64 Halozyme Ultrafast Insulin 64 Phase Ib II 64 GRNVAC1 64 TSX VENTURE GAP 64 Qutenza TM 64 HepeX B TM 64 OTC BB PVCT http:/www.pvct.com 64 Aloprim TM allopurinol sodium 64 TBC# 64 vidofludimus 64 TNF alpha antagonist 64 MultiStem ® 64 secretory phospholipase A2 64 Tyrosine Kinase Inhibitor 64 next generation URAT1 64 Pafuramidine 64 AKT inhibitor 64 commercialize conjugates consisting 64 ELND-#/AZD-# 64 r hGH 64 PresbyLens ® 64 Loramyc TM 64 HuMax TF 64 multicenter Phase III 64 immatics 64 DU #b 64 DURECT proprietary 64 aldehyde dehydrogenase ALDH2 deficiency 64 low toxicity bioscience 64 SARMs 64 Temsirolimus 64 antimitotic 64 radiation sensitizer 64 diarrhea predominant irritable 64 ChromoCure develops 64 solid tumors ZYBRESTAT 64 Nasdaq EPCT 64 Vidaza R 64 bladder ovarian 64 subsidiary Cira Biosciences 64 humanized monoclonal antibodies 64 CYCLOSET ® 64 drug GAP #B# 64 QUADRAMET R 64 oral PTH 64 product ProBiora3 64 alvespimycin 64 Thalomid ® 64 candidates Azedra 64 leading oral taxane 64 treat chronic sinusitis 64 2A receptor agonist 64 cancer immunotherapies 64 Nasdaq CYCC 64 IMC #B 64 GED aPC 64 investigational therapies 64 Quinamed 64 commercialize SGN 64 t2cure GmbH 64 stage hypoxia activated 64 include Altastaph TM 64 MKC# 64 receptor tyrosine kinase inhibitor 64 RNAi therapeutic targeting 64 Micromet proprietary BiTE 64 resorbable biomaterials 64 DPX Survivac 64 Dyax logo 64 commercialize ZYFLO CR 64 NYSE Amex RGN 64 Locteron exclusively 64 proprietary MSCRAMM protein 64 Cerashield ™ 64 OTC Bulletin Board LWLG 64 Chimigen 64 interstitial cystitis IC 64 Tissue Repair Company 64 proprietary dermal 64 cilengitide 64 biologic DMARD 64 AdhTAP 64 Namenda Memantine HCl 64 PREOS R 64 Pruvel ™ 64 Retisert ® 64 Oxytrol R 64 TOCOSOL 64 SynCon 64 MediGene focuses 64 Small Molecule 64 anticoagulant reversing agent 64 CDK cyclin dependent 64 reslizumab 64 vitro pharmacology 64 sorafenib tablets 64 proprietary hydrogel 64 Nerve Targeting Drug 64 class mGluR5 inhibitor 64 pathophysiological effects 64 CINTREDEKIN BESUDOTOX 64 HGS ETR2 63 phage display technology 63 IMRX 63 adrenergic regulation 63 triggers apoptosis programmed 63 Shows Promise Against 63 immunologic diseases 63 Vitrasert ® 63 renin inhibition promising 63 Dynavax proprietary 63 BioSante licensees 63 Lenocta 63 molecular imaging radiopharmaceuticals 63 calcium phosphate nanotechnology CaP 63 OvaRex R 63 TNFerade TM 63 selective angiogenic kinase inhibitor 63 HeartMate ® 63 class anticancer quinolone 63 VIBATIV ™ 63 Novosom 63 NB S# strontium malonate 63 PEG irinotecan 63 ZEVALIN ® 63 Nasdaq PGNX 63 imaging radiopharmaceuticals 63 NEUGENE R 63 Curaxin 63 Surface Plasmon Resonance SPR 63 Files Investigational